Literature DB >> 10669937

Mechanisms and new approaches for the allogeneic blood transfusion-induced immunomodulatory effects.

K J Kao1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10669937     DOI： 10.1016/s0887-7963(00)80112-1

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN： 0887-7963


× No keyword cloud information.
  7 in total

1.  Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: results of a prospective, randomized, controlled clinical trial.

Authors:  Jill M Cholette; Kelly F Henrichs; George M Alfieris; Karen S Powers; Richard Phipps; Sherry L Spinelli; Michael Swartz; Francisco Gensini; L Eugene Daugherty; Emily Nazarian; Jeffrey S Rubenstein; Dawn Sweeney; Michael Eaton; Norma B Lerner; Neil Blumberg
Journal:  Pediatr Crit Care Med       Date:  2012-05       Impact factor: 3.624

2.  Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database.

Authors:  Lauren S Prescott; Thomas A Aloia; Alaina J Brown; Jolyn S Taylor; Mark F Munsell; Charlotte C Sun; Kathleen M Schmeler; Charles F Levenback; Diane C Bodurka
Journal:  Gynecol Oncol       Date:  2014-11-14       Impact factor: 5.482

3.  Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice.

Authors:  Carlton C Barnett; Adam W Beck; Shane E Holloway; Marguerite Kehler; Marie K Schluterman; Rolf A Brekken; Jason B Fleming; Christopher C Silliman
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

Review 4.  Exploiting the critical perioperative period to improve long-term cancer outcomes.

Authors:  Maya Horowitz; Elad Neeman; Eran Sharon; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2015-01-20       Impact factor: 66.675

5.  Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases.

Authors:  Akshat Saxena; Sarah J Valle; Winston Liauw; David L Morris
Journal:  J Gastrointest Surg       Date:  2017-05-30       Impact factor: 3.452

6.  Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study.

Authors:  Mette Ørskov; Maria Iachina; Rikke Guldberg; Ole Mogensen; Bente Mertz Nørgård
Journal:  BMJ Open       Date:  2016-04-21       Impact factor: 2.692

7.  Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer.

Authors:  Eun-Ki Min; Jae Uk Chong; Ho Kyoung Hwang; Sang Joon Pae; Chang Moo Kang; Woo Jung Lee
Journal:  World J Gastroenterol       Date:  2017-01-28       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.